⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 15, 2024Open Access

Supplementary Figure S3 from Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Miguel Martín Rachel Yoder Roberto Salgado Marı́a del Monte-Millán Enrique L. Álvarez Isabel Echavarría Joshua M. Staley Anne O’Dea Lauren Nye Shane R. Stecklein Coralia Bueno Yolanda Jerez María Cebollero Oscar Bueno José Á. García-Sáenz Fernando Moreno Uriel Bohn Henry Gómez Tatiana Massarrah Qamar J. Khan Andrew K. Godwin Sara López‐Tarruella Priyanka Sharma

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Survival by pathologic response

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Martín et al. (2024) studied this question.

synapsesocial.com/papers/68e6a13db6db643587624dca https://doi.org/10.1158/1078-0432.25826562.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy2024
2Supplementary Figure S2 from Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy2024
3Supplementary Figure S2 from Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy2024
4Supplementary Figure S4 from Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy2024
5Supplementary Figure S4 from Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy2024